UTHR Financial Facts
Net income per basic common share (in dollars per share): 3.75Interest expense: -500K
See Full Income Statement
Inventories, net: 92.4M
Total current liabilities: 314.6M
See Full Balance Sheet
United Therapeutics Corp. (UTHR) Earnings
|
Expand Research on UTHR
Next EPS Date | 5/1/24 | EPS Growth Rate | +19.1% |
---|---|---|---|
Average EPS % Beat Rate | +6.1% | Revenue Growth Rate | +22.3% |
Average % Move 1-Wk after EPS | -0.1% | Normal Earnings Time | Before Open |
Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
---|---|---|---|---|---|---|---|---|---|---|---|
7/28/11 | Q211 | $1.49 | $0.53 | +$0.96 | $183.75M | $180.84M | N/A | Details | |||
10/28/10 | Q310 | $0.66 | $0.54 | +$0.12 | N/A | N/A | N/A | Details | |||
2/15/11 | Q410 | $1.27 | $0.62 | +$0.65 | $166.5M | $174.87M | N/A | Details | |||
4/28/11 | Q111 | $1.29 | $0.64 | +$0.65 | $165.6M | $178.02M | N/A | Details | |||
10/27/11 | Q311 | $1.65 | $0.73 | +$0.92 | $201.7M | $194.77M | N/A | Details | |||
2/14/12 | Q411 | $0.79 | $0.87 | -$0.08 | $195.2M | $204.81M | N/A | Details | |||
4/26/12 | Q112 | $1.32 | $0.93 | +$0.39 | $204.2M | $203.91M | N/A | Details | |||
7/26/12 | Q212 | $1.34 | $1.12 | +$0.22 | $225.6M | $213.33M | N/A | Details |